Circulation Journal
Online ISSN : 1347-4820
Print ISSN : 1346-9843
ISSN-L : 1346-9843
Images in Cardiovascular Medicine
Definite Acute Myocarditis After Coronavirus Disease 2019 mRNA Vaccination
Manabu MaedaTsuyoshi IsawaNorio Tada
著者情報
ジャーナル オープンアクセス HTML
電子付録

2022 年 86 巻 4 号 p. 724-

詳細

A 29-year-old man with no medical history or coronavirus disease 2019 (COVID-19) infection developed chest pain 4 days after his first dose of the Moderna mRNA COVID-19 vaccine (Moderna, MA, USA). On presentation to the emergency department, reverse transcription–polymerase chain reaction test for COVID-19 was negative, but creatine kinase (686 U/L; reference, 40–220), creatine kinase MB isoenzyme (47 U/L; reference, 0–24), and troponin I (18.4ng/mL; reference, <0.026) were elevated. Electrocardiogram was normal except for ST-T changes in leads III, V1, and aVL (Figure A); echocardiogram and coronary angiogram were unremarkable (Figure B, Supplementary Movie); serology tests for cardiotropic viruses were negative. Cardiac magnetic resonance (CMR) imaging 6 days after initial symptoms (Figure C,D) indicated acute myocarditis. Spontaneous recovery occurred within 1 week without any specific treatment. CMR 3 weeks after initial symptoms revealed reduced signal changes in the anterior and lateral walls (Figure E,F). This is one of the first reports of definite acute myocarditis after COVID-19 vaccination in Japan. Although attention has been paid to the development of myocarditis after COVID-19 vaccination,1 the causality between the vaccine and myocarditis remains unclarified.

Figure.

(A) Normal ECG except for ST-T changes in leads III, V1, and aVL. (B) No significant coronary artery stenosis. (C) Fat-saturation T2-weighted images display focal myocardial edema involving the anterior and lateral walls (arrow), especially in the basal lateral segment. (D) Areas in (C) corresponded with inflammatory necrosis observed on late gadolinium enhancement imaging (arrowhead). (E, arrow) Reduced signal changes in the anterior and lateral walls on fat-saturation T2-weighted and (F, arrowhead) late gadolinium enhancement images acquired 3 weeks after initial symptoms.

Disclosures

None.

IRB Information

The study was approved by the Institutional Review Board of Sendai Kousei Hospital on August 27, 2021 (Approval no. 3-47).

Supplementary Files

Supplementary Movie. Echocardiogram.

Please find supplementary file(s);

http://dx.doi.org/10.1253/circj.CJ-21-0840

Reference
 
© 2022, THE JAPANESE CIRCULATION SOCIETY

This article is licensed under a Creative Commons [Attribution-NonCommercial-NoDerivatives 4.0 International] license.
https://creativecommons.org/licenses/by-nc-nd/4.0/
feedback
Top